Dimercaprol
FDA-approved product (injectable, injection), marketed as Bal.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 0 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLNo approved indication recorded
ChEMBL records no approved indication for Dimercaprol. Its therapeutic class is shown instead.
- WHO therapeutic group
- Antidotes
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
No supported pathogen reaches ≥40% AI-predicted activity for Dimercaprol, so it is not among the repurposing candidates. Its predictions are shown below.
AI-predicted activity
AI prediction · nothing measured- MRSA15.7% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli13.3% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae8.8% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis16.7% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Dimercaprol with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Mefloquine HydrochlorideExisting use: Malaria, Plasmodium falciparum malaria, Plasmodium vivax malaria81.8% AI-predicted activityagainst M. tuberculosisLab records exist8 registered studies
- KetoconazoleExisting use: Adrenal gland disease, Blastomycosis, Cushing syndrome and 3 more81.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- LevoketoconazoleExisting use: Adrenal gland disease, Adrenal gland hyperfunction, Cushing syndrome81.2% AI-predicted activityagainst M. tuberculosis6 registered studies
- Fluphenazine DecanoateExisting use: Mental or behavioural disorder, Psychosis80.7% AI-predicted activityagainst M. tuberculosis4 registered studies
- Fluphenazine EnanthateExisting use: Mental or behavioural disorder, Psychosis80.7% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- NifurtimoxExisting use: American trypanosomiasis, Chagas disease, Leishmaniasis and 1 more78.4% AI-predicted activityagainst M. tuberculosis19 registered studies
- Fluphenazine HydrochlorideExisting use: Mental or behavioural disorder, Psychosis77.8% AI-predicted activityagainst M. tuberculosis5 registered studies
- NitazoxanideExisting use: Amebiasis, Diarrhea77.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- TopiramateExisting use: Epilepsy, Lennox-Gastaut syndrome, Migraine disorder and 1 more77.4% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- TrabectedinExisting use: Cancer, Dedifferentiated liposarcoma, Leiomyosarcoma and 7 more76.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Chlorpromazine HydrochlorideExisting use: Conduct disorder, Mental or behavioural disorder, Nausea and vomiting and 3 more75.0% AI-predicted activityagainst M. tuberculosis33 registered studies
- ProchlorperazineExisting use: Anxiety disorder, Nausea and vomiting, Psychosis and 1 more74.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax
NCT07478471 · start 2027-05
Registered record
- Registry ID
- NCT07478471
- Conditions
- Infections, Bacterial
- Interventions
- Collection of samples
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Not yet recruiting
- Start
- 2027-05
- Completion
- 2030-12
- Enrolment
- 10
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInfections, BacterialInterventionCollection of samplesPhaseNot recordedRegistry statusNot yet recruitingClusterVAP: Multicentre Proteomic Endotyping of Ventilator-associated Pneumonia
NCT07245888 · start 2026-05-01
Registered record
- Registry ID
- NCT07245888
- Conditions
- Ventilator Acquired Pneumonia; Mechanical Ventilation Complication
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2026-05-01
- Completion
- 2027-12
- Enrolment
- 400
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVentilator Acquired Pneumonia; Mechanical Ventilation ComplicationInterventionNot recordedPhaseNot recordedRegistry statusRecruitingAssociation of Nutrition and T Cell Immune Activity With Disease Progression in Nontuberculous Mycobacterial Pulmonary Disease
NCT07363798 · start 2026-01
Registered record
- Registry ID
- NCT07363798
- Conditions
- Nontuberculous Mycobacterial Pulmonary Disease; Nontuberculous Mycobacterial Lung Disease
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Not yet recruiting
- Start
- 2026-01
- Completion
- 2027-12-31
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNontuberculous Mycobacterial Pulmonary Disease; Nontuberculous Mycobacterial Lung DiseaseInterventionNot recordedPhaseNot recordedRegistry statusNot yet recruitingHerpes Simplex Virus Type 1 Infection/Reactivation of Patients With Severe Pneumonia(the HSV-SP Study)
NCT06936683 · start 2025-06-01
Registered record
- Registry ID
- NCT06936683
- Conditions
- Severe Pneumonia
- Interventions
- Bronchoalveolar Lavage (BAL) via Fiberoptic Bronchoscopy; throat Swab
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Not yet recruiting
- Start
- 2025-06-01
- Completion
- 2027-10-01
- Enrolment
- 323
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSevere PneumoniaInterventionBronchoalveolar Lavage (BAL) via Fiberoptic Bronchoscopy; throat SwabPhaseNot recordedRegistry statusNot yet recruitingDevelopment of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
NCT06317909 · start 2024-08-09
Registered record
- Registry ID
- NCT06317909
- Conditions
- Mild Allergic Asthma
- Interventions
- allergen challenge
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Recruiting
- Start
- 2024-08-09
- Completion
- 2027-03
- Enrolment
- 15
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMild Allergic AsthmaInterventionallergen challengePhaseNot applicableRegistry statusRecruitingPattern Of Isolated Fungi From Bronchoalveolar Lavage Among Patients With Bronchial Asthma
NCT06376617 · start 2024-04-25
Registered record
- Registry ID
- NCT06376617
- Conditions
- Bronchial Asthma
- Interventions
- fibroptic bronchoscopy
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2024-04-25
- Completion
- 2025-05-20
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBronchial AsthmaInterventionfibroptic bronchoscopyPhaseNot applicableRegistry statusUnknownThe Efficacy and Adverse Reactions of Neotetracycline in the Treatment of GNB Infections
NCT06990126 · start 2024-03-01
Registered record
- Registry ID
- NCT06990126
- Conditions
- Clinical Efficacy and Safety
- Interventions
- bronchoscope
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Enrolling by invitation
- Start
- 2024-03-01
- Completion
- 2026-07-30
- Enrolment
- 300
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionClinical Efficacy and SafetyInterventionbronchoscopePhaseNot recordedRegistry statusEnrolling by invitationBAL Contribution to Lung Cryo-TBB in ILD
NCT07130110 · start 2023-12-20
Registered record
- Registry ID
- NCT07130110
- Conditions
- Bronchoalveolar Lavage (BAL); Transbronchial Cryobiopsy; Interstitial Lung Disease (ILD)
- Interventions
- Transbronchial cryobiopsy; Bronchoalveolar Lavage
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2023-12-20
- Completion
- 2024-09-30
- Enrolment
- 127
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBronchoalveolar Lavage (BAL); Transbronchial Cryobiopsy; Interstitial Lung Disease (ILD)InterventionTransbronchial cryobiopsy; Bronchoalveolar LavagePhaseNot applicableRegistry statusCompletedALI/ARDS Clinical Sub-phenotyping Study
NCT06123962 · start 2023-12-14
Registered record
- Registry ID
- NCT06123962
- Conditions
- Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
- Interventions
- Collect peripheral blood and bronchoalveolar lavage fluid
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2023-12-14
- Completion
- 2025-12-31
- Enrolment
- 1,500
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)InterventionCollect peripheral blood and bronchoalveolar lavage fluidPhaseNot recordedRegistry statusRecruitingMultidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
NCT06475976 · start 2023-12-05
Registered record
- Registry ID
- NCT06475976
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Chest computed tomography (CT) with angiography; Bronchoscopy with bronchoalveolar lavage; Echocardiography; 24 hour esophageal pH ("potential of hydrogen") - multichannel intraluminal impedance (MII) monitoring (reflux testing)
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2023-12-05
- Completion
- 2029-07-31
- Enrolment
- 130
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBronchopulmonary DysplasiaInterventionChest computed tomography (CT) with angiography; Bronchoscopy with bronchoalveolar lavage; Echocardiography; 24 hour esophageal pH ("potential of hydrogen") - multichannel intraluminal impedance (MII) monitoring (reflux testing)PhaseNot recordedRegistry statusRecruitingMetagenomic NGS for Diagnosis of Pneumonia
NCT05979350 · start 2023-08-07
Registered record
- Registry ID
- NCT05979350
- Conditions
- Pneumonia; Diagnosis
- Interventions
- Metagenomic next-generation sequencing; Standard work-up for pneumonia
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Active not recruiting
- Start
- 2023-08-07
- Completion
- 2025-11-30
- Enrolment
- 114
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPneumonia; DiagnosisInterventionMetagenomic next-generation sequencing; Standard work-up for pneumoniaPhaseNot applicableRegistry statusActive not recruitingFlexible Bronchoscopy in Resistant Pneumonia in PICU
NCT07421440 · start 2023-02-05
Registered record
- Registry ID
- NCT07421440
- Conditions
- Pneumonia; Resistant Pneumonia; Resistant Pneumonia in Critically Ill Pedaitric Patients
- Interventions
- Flexible fiberoptic bronchoscopy with bronchoalveolar lavage (BAL)
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2023-02-05
- Completion
- 2025-08-03
- Enrolment
- 70
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPneumonia; Resistant Pneumonia; Resistant Pneumonia in Critically Ill Pedaitric PatientsInterventionFlexible fiberoptic bronchoscopy with bronchoalveolar lavage (BAL)PhaseNot recordedRegistry statusCompletedMolecular vs Conventional Microbiologic Diagnosis for Infections in Lung Transplantation
NCT05960383 · start 2023-02-02
Registered record
- Registry ID
- NCT05960383
- Conditions
- Lung Transplant Infection; Molecular Diagnostic; Bacterial Infections; Pneumonia; Tracheobronchitis
- Interventions
- BioFire Pneumonia Panel Plus
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2023-02-02
- Completion
- 2024-11-01
- Enrolment
- 53
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionLung Transplant Infection; Molecular Diagnostic; Bacterial Infections; Pneumonia +1 moreInterventionBioFire Pneumonia Panel PlusPhaseNot recordedRegistry statusUnknownProspective Study on the Efficacy and Safety of Bronchoalveolar Lavage Combined With Pathogen Metagenomic Sequencing Technology in the Diagnosis of Immune Checkpoint Inhibitor Associated Pneumonia
NCT06192303 · start 2023-01-01
Registered record
- Registry ID
- NCT06192303
- Conditions
- Immune Checkpoint Inhibitor Associated Pneumonia
- Interventions
- Bronchoalveolar lavage and pathogen metagenomic sequencing
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2023-01-01
- Completion
- 2026-01-01
- Enrolment
- 104
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionImmune Checkpoint Inhibitor Associated PneumoniaInterventionBronchoalveolar lavage and pathogen metagenomic sequencingPhaseNot recordedRegistry statusUnknownRemodelling of the Lower Airways in Chronic Cough
NCT07659860 · start 2022-10-01
Registered record
- Registry ID
- NCT07659860
- Conditions
- Chronic Cough
- Interventions
- chest computed tomography and bronchoscopy
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Recruiting
- Start
- 2022-10-01
- Completion
- 2026-08-30
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic CoughInterventionchest computed tomography and bronchoscopyPhaseNot recordedRegistry statusRecruiting